Cuts Threaten Basic Research In Australia

SYDNEY—The Australian government’s increasingly pragmatic attitude toward academic research has dismayed many scientists here and reinforced their feeling that the universities’ central activities are under assault. Their concerns recently have focused on the Australian Research Grants Scheme (ARGS), the annual round of competitive grants for scientists and others at the country’s 20 universities. Total funding under ARGS for 1988 is $32.3 million Australian ($22 milli

Written byPeter Pockley
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

SYDNEY—The Australian government’s increasingly pragmatic attitude toward academic research has dismayed many scientists here and reinforced their feeling that the universities’ central activities are under assault.

Their concerns recently have focused on the Australian Research Grants Scheme (ARGS), the annual round of competitive grants for scientists and others at the country’s 20 universities. Total funding under ARGS for 1988 is $32.3 million Australian ($22 million U.S.), some $75,000 less than this year’s figure. That reduction is compounded by the country’s current inflation rate of 8 or 9 percent. Announcement of the grants was delayed several weeks as government minister John Dawkins personally screened the titles of scientific proposals to avoid any political embarrassment. Conservative opponents earlier this year had ridiculed grants that they thought were wasteful or irrelevant, in initiation of the “Golden Fleece Awards” given out by U.S. Sen. William Proxmire (D-Wis.). David Penington, vice chancellor-elect of the University ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies